Delivery Order SPE2DR25D6028-SPE2DR26FARVD
- Not listed
- The Defense Logistics Agency awarded a $1,750.20 delivery order to AmerisourceBergen Drug Corp for Atropine 1 mg/ml vials, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,399.32 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/ml vials. This competitively awarded, firm fixed-price contract has no set-aside designation and was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $16,471.67. The contract was competitively awarded without set-aside provisions and requires completion by June 9, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency's Medical Supply Chain awarded a $4,366.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials. The contract, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle. Performance will be executed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Atropine 0.4 mg/ml vials with a ceiling value of $1,375.09. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Atropine 1 mg/10 mL syringes with a ceiling value of $1,681.81. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The product will be performed and delivered from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,577.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atropine 0.4 mg/ml in vial format. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract is set to be completed by August 8, 2025, with performance occurring at the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $6,487.05, represents a non-competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Atropine 1 mg/mL vials. This firm fixed price delivery order, valued at $1,339.21, represents a non-competitive award and is set to be completed by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide Atropine 1 mg/mL vials. The $21,780.88 contract has a completion date of March 1, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARVDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,324.70 to AmerisourceBergen Drug Corp for the supply of Atropine 1mg/1ml in quantities of 25 units. This firm fixed price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by November 19, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements through open competition, ranging from small-value transactions to substantial orders. This delivery order for Atropine, an essential emergency medication used in military and veteran healthcare settings, exemplifies the company's role in supplying critical medical commodities to support defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 11/18/25 |